Vladimir Juras1,2, Markus Schreiner3, Didier Laurent4, Stefan Zbyn5, Vladimir Mlynarik1, Pavol Szomolanyi1, Celeste Scotti4, Joerg Goldhahn4, Harry Haber4, Ewa Kubiak4, Stefan Marlovits6, Rahel Heule7, Oliver Bieri7, Ivan Frollo8, and Siegfried Trattnig1,9
1Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria, 2Department of Imaging Methods, Institute of Measurement Science, Bratislava, Slovakia, 3Department of Orthopedics, Medical University of Vienna, Vienna, Austria, 4Novartis Institutes for Biomedical Research, Basel, Switzerland, 5Research Unit of Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland, 6Department of Traumatology, Medical University of Vienna, Vienna, Austria, 7Division of Radiological Physics, Department of Radiology, University of Basel Hospital, Basel, Switzerland, 8Slovak Academy of Sciences, Institute of Measurement Science, Bratislava 4, Slovakia, 9Christian Doppler Laboratory for Clinical Molecular MR Imaging, Vienna, Austria
Synopsis
T2 maps were
assessed as a potential marker for the long-term follow-up of the patients with
cartilage lesions ICRS Grade I-II in five time points (baseline, 8 days, 3, 6
and 12 months). For the T2 mapping, a 3D triple echo steady state sequence
which is capable of delivering high quality high-resolved T2 maps at ultra-high
field MRI was used. We observed a significant decrease in T2 values at 3T over
time in superficial zone of the cartilage defect. There was no statistically
significant change at 7T. T2 mapping could be used in the future as a good
alternative to cartilage biopsies in clinical trials on new therapies aimed at
cartilage regeneration.
Background & Purpose
T2
mapping has been previously demonstrated as a reliable quantitative method for
assessing the collagen network damage and water content in human articular
cartilage 1,2. The sensitivity and reliability of T2 mapping for subtle
cartilage lesions at different fields have not yet been sufficiently
investigated. The purpose of this study was to investigate MRI T2
mapping as a possible marker to follow-up of the patients up to one year after
cartilage injury and to compare the reliability at high field (3T) and
ultra-high field (7T).Methods and Materials:
Twenty-one patients with femoral
cartilage defect(s) in the knee joint after traumatic injury with ICRS Grade I
and II (mean age, 46.3/11.1 years; 12 males/9 females) were examined. T2 maps were acquired for each of these
patients on two MR scanners: 3T Prisma Fit (Siemens, Erlangen, Germany) and 7T Magnetom
scanner (Siemens Healthcare, Germany). T2
relaxation times were calculated using a 3D-Triple Echo Steady State sequence
(3D-TESS)3. Regions of interest (ROIs) were defined on morphological
images in the region suspicious for a cartilage defect and in a region of
normal-appearing cartilage (weight- and non-weight bearing region) in both deep
and superficial cartilage layers and transferred onto T2
maps. The measurements were repeated at five time-points (baseline, 8 days, 3
months, 6 months and 12 month after baseline). Student’s t-test was used to
determine the potential differences in T2
over time at different field strengths.Results
Illustrative
T2 maps with the ROI position are shown on Fig. 1. We observed a
decrease of T2 values at 3T, whilst the T2 values at 7T
did not change. At 3T we found a statistical significant drop of T2
in the superficial layer of the defect between baseline and 6 month follow-up:
41.85±8.57ms to 36.21±7.15ms (change of 5.64±1.41ms, p = 0.0321) and again in
the superficial layer between baseline and 12 month follow-up: 41.85±8.57ms to
35.28±4.93ms (change of 6.57±3.63ms, p = 0.0381). No statistical significance
was found in 7T T2 values. The T2 values progress is
visualized in Fig. 2.Conclusion
T2 mapping with 3D-TESS enables monitoring of biochemical
changes in low-grade cartilage lesions over time. It seems that T2
values acquired at 3T are more sensitive to collagen network because of an echo
time of ~4ms and the resulting contribution of short T2 component to
the signal which is already decayed at 7T. Hence, T2
may be considered as a valuable marker for monitoring cartilage development
after traumatic injury causing alterations to the collagen matrix or/and
regenerative therapy.Acknowledgements
This work was supported by the
Slovak Research and Development Agency: APVV-15-0029, Grant Agency of the
Slovak Academy of Sciences (VEGA 2/0001/17) and Austrian Science Fund (FWF)
KLI541-B30.References
[1] Mosher TJ at al. Cartilage
MRI T2 relaxation time mapping: overview and applications, Semin Musculoskelet
Radiol 2004; 08(4): 355-368
[2] Liess, C at al. Detection
of changes in cartilage water content using MRI T2-mapping in vivo, Osteoarthritis
and Cartilage 2002, 10(12): 907-913
[3] Heule R et al. Triple echo
steady-state (TESS) relaxometry, Magnetic Resonance in Medicine 2004; 71(1)
230–237